ok if ive reconstructed the timeline correctly
it appears i got convinced to do my current dosage of CPA (~12.5mg) in 2019 based on the recommendations of a bunch of internet weirdos when there were no studies of this dosage in trans people? (historically 25-50mg or more)
and it appears since then a bunch of studies have come out and WPATH has endorsed the views of the internet weirdos and now thinks 10mg is best
Follow
it appears the internet weirdos have not manage to quite make bicalutamide a thing, tbh i suspect googling around enzalutamide will become a thing when it comes off patent in a few years
(note that aiui the risk falls a lot faster than linearly for buproprion)
like the wikipedia says the main scary side effect is a 1% risk of seizures but i feel like we'll probably need like a tenth of the dose they ran the experiment on
and assuming the risk falls linearly we're in buproprion territory here